199 related articles for article (PubMed ID: 29270001)
1. High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction.
Gavazzoni M; Gorga E; Derosa G; Maffioli P; Metra M; Raddino R
Drug Des Devel Ther; 2017; 11():3425-3434. PubMed ID: 29270001
[TBL] [Abstract][Full Text] [Related]
2. High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis.
Priti K; Agrawal A; Ranwa BL
Indian Heart J; 2017; 69(4):453-457. PubMed ID: 28822510
[TBL] [Abstract][Full Text] [Related]
3. Intensive atorvastatin improves endothelial function and decreases ADP-induced platelet aggregation in patients with STEMI undergoing primary PCI: A single-center randomized controlled trial.
Xu X; Liu Y; Li K; Wang P; Xu L; Yang Z; Yang X
Int J Cardiol; 2016 Nov; 222():467-472. PubMed ID: 27505335
[TBL] [Abstract][Full Text] [Related]
4. Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction.
Kandhai-Ragunath JJ; Doggen CJM; van der Heijden LC; Kok MM; Zocca P; de Wagenaar B; Doelman C; Jørstad HT; Peters RJG; von Birgelen C
Heart Vessels; 2018 Sep; 33(9):978-985. PubMed ID: 29541845
[TBL] [Abstract][Full Text] [Related]
5. [The impact of different doses of atorvastatin on plasma endothelin and platelet function in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention].
Xu XR; Li KB; Wang P; Xu L; Liu Y; Yang ZS; Yang XC
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):932-936. PubMed ID: 27916047
[No Abstract] [Full Text] [Related]
6. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
9. Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction.
García-Méndez RC; Almeida-Gutierrez E; Serrano-Cuevas L; Sánchez-Díaz JS; Rosas-Peralta M; Ortega-Ramirez JA; Palomo-Villada JA; Isordia-Salas I; Alonso-Bravo RM; Borrayo-Sanchez G
Arch Med Res; 2018 Nov; 49(8):620-629. PubMed ID: 30446246
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
[TBL] [Abstract][Full Text] [Related]
11. The functional effect of atorvastatin dose-dependent via inflammation factors on acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention.
Liu Q; Wang Y; Cheng X
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):215-219. PubMed ID: 30222665
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry.
Kandhai-Ragunath JJ; Doggen CJ; Jørstad HT; Doelman C; de Wagenaar B; IJzerman MJ; Peters RJ; von Birgelen C
Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):664-71. PubMed ID: 27068872
[TBL] [Abstract][Full Text] [Related]
14. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
[TBL] [Abstract][Full Text] [Related]
15. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction evaluated by peripheral arterial tonometry is related with peak TnI values in patients with ST elevation myocardial infarction treated with primary angioplasty.
Baptista SB; Faustino M; Simões J; Nédio M; Monteiro C; Lourenço E; Leal P; Farto eAbreu P; Gil V
Microvasc Res; 2016 May; 105():34-9. PubMed ID: 26721522
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Effects of Ticagrelor and Clopidogrel on Inflammatory Factors, Vascular Endothelium Functions and Short-Term Prognosis in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention: a Pilot Study.
Gao CZ; Ma QQ; Wu J; Liu R; Wang F; Bai J; Yang XJ; Fu Q; Wei P
Cell Physiol Biochem; 2018; 48(1):385-396. PubMed ID: 30016801
[TBL] [Abstract][Full Text] [Related]
18. Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).
Takayama T; Hiro T; Yoda S; Fukamachi D; Haruta H; Kogo T; Mineki T; Murata H; Oshima T; Hirayama A
Heart Vessels; 2018 Jun; 33(6):590-594. PubMed ID: 29209775
[TBL] [Abstract][Full Text] [Related]
19. Early peripheral endothelial dysfunction predicts myocardial infarct extension and microvascular obstruction in patients with ST-elevation myocardial infarction.
Bravo Baptista S; Faustino M; Brizida L; Loureiro J; Augusto J; Abecasis J; Monteiro C; Leal P; Nédio M; Farto E Abreu P; Gil V; Morais C
Rev Port Cardiol; 2017 Oct; 36(10):731-742. PubMed ID: 29033166
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
